Spikes - covid-19 and share price9 Jun 2020 00:02
We 'may' be beyond huge spikes in daily deaths and new cases in UK.
Without a vaccine or assurance of ongoing lifetime immunity the virus will just perculate indefintely and kill at will.
The path towards a solution is at the very early stages. People who talk about 'back to normal' are those looking for trading spikes.
Sentiment and complacency may switch, but that doesn't change reality. Sentiment changes on the flip of a coin.
Orph will be a direct beneficiary from playing its role in working towards finding a covid-19 solution.
Orph - as a profitable business - makes good sense @ mkt cap of £100 million [2020] plus potential of Imutex, even without covid-19. It remains a business with growth potential into 2021 within a world that will remain focussed on virus vs vaccine for quite some time to come. Even if, as Donal Trump said, Covid-19 magically disappeared, we remain in the right market sector with a spotlight upon us that wasn't so bright in January 2020.
Personally, the sooner this share gets rid of investors/traders searching for a covid 'quick win' the better.